Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00312039
Status:
COMPLETED
Last Update Posted:
2023-08-25
First Post:
2006-04-05
Brief Title:
Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Organization Data
Organization:
Alexion Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ACH443-014A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alexion Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Achillion a wholly owned subsidiary of Alexion | INDUSTRY |